CAS: 180288-69-1 - Trastuzumab
- Sinonimi:
- Trastuzumab [USAN:INN]
- Herceptin
- Immunoglobulin G 1 (human-mouse monoclonal rhuMab HER2gamma1-chain antihuman p185(sup c-erbB2) receptor), disulfide with human-mouse monoclonal rhuMab HER2 light chain, dimer
- Unii-P188Anx8Ck
- Immunoglobulin G1, anti-(human p185neu receptor) (human-mouse monoclonal rhuMab HER2 gamma1-chain), disulfide with human-mouse monoclonal rhuMab HER2 light chain, dimer
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | Trastuzumab REF: TM-T9912CAS: 180288-69-1 | 98% - 99.50% | 152,00 €~1.831,00 € | Mar 21 Gen 25 |
 | Trastuzumab - 20mg/ml in PBS REF: 3D-FT65040CAS: 180288-69-1 | Min. 95 Area-% | 248,00 €~1.676,00 € | Ven 24 Gen 25 |
Trastuzumab
CAS:180288-69-1
Trastuzumab is a humanized monoclonal antibody for patients with invasive breast cancers that overexpress HER2.
Purezza:
98% - 99.50%
Colore e forma:
Liquid
Peso molecolare:
Approximately 145.53 kDa
- Inibitori
- EGFR
- Adattatori Tirosin-chinasi
- Segnalazione PI3K/Akt/mTOR
- Vedere altre categorie
- Trastuzumab e Impurezze
Ref: TM-T9912
| 1mg | 152,00 € | ||
| 5mg | 511,00 € | ||
| 10mg | 640,00 € | ||
| 25mg | 1.009,00 € | ||
| 50mg | 1.364,00 € | ||
| 100mg | 1.831,00 € |
Consegna stimata in Stati Uniti, il Martedì 21 Gennaio 2025
Trastuzumab - 20mg/ml in PBS
CAS:180288-69-1
Monoclonal antibody against HER2 for breast cancer treatment
Purezza:
Min. 95 Area-%
Colore e forma:
Clear Liquid
Ref: 3D-FT65040
| 1mg | 248,00 € | ||
| 10mg | 839,00 € |
Consegna stimata in Stati Uniti, il Venerdì 24 Gennaio 2025
